Abstract

Calcification is a detrimental process in vascular ageing and in diseases such as atherosclerosis and arthritis. In particular, small calcium phosphate (CaP) crystal deposits are associated with inflammation and atherosclerotic plaque de-stabilisation. We previously reported that CaP particles caused human vascular smooth muscle cell (VSMC) death and that serum reduced the toxic effects of the particles. Here, we found that the serum proteins fetuin-A and albumin (≥1 µM) reduced intracellular Ca2+ elevations and cell death in VSMCs in response to CaP particles. In addition, CaP particles functionalised with fetuin-A, but not albumin, were less toxic than naked CaP particles. Electron microscopic studies revealed that CaP particles were internalised in different ways; via macropinocytosis, membrane invagination or plasma membrane damage, which occurred within 10 minutes of exposure to particles. However, cell death did not occur until approximately 30 minutes, suggesting that plasma membrane repair and survival mechanisms were activated. In the presence of fetuin-A, CaP particle-induced damage was inhibited and CaP/plasma membrane interactions and particle uptake were delayed. Fetuin-A also reduced dissolution of CaP particles under acidic conditions, which may contribute to its cytoprotective effects after CaP particle exposure to VSMCs. These studies are particularly relevant to the calcification observed in blood vessels in patients with kidney disease, where circulating levels of fetuin-A and albumin are low, and in pathological situations where CaP crystal formation outweighs calcification-inhibitory mechanisms.

Highlights

  • The biosynthesis of calcium phosphate (CaP) crystals is a tightly regulated physiological process occurring in bones and teeth

  • We demonstrated that fetuin-A slowed the dissolution of CaP particles under acidic conditions which may explain why vascular smooth muscle cell (VSMC) survived in the presence of fetuin-A, despite the presence of numerous intracellular CaP particles

  • We found that CaP particles induced cell death in VSMCs, and that this involved progressive plasma membrane damage and cellular uptake of particles

Read more

Summary

Introduction

The biosynthesis of calcium phosphate (CaP) crystals is a tightly regulated physiological process occurring in bones and teeth. Deposition of CaP crystals at non-skeletal locations (ectopic calcification) occurs in blood vessels in association with ageing and in several diseases including atherosclerosis, arthritis and cancer. The amount of calcification in arteries correlates positively with the degree of atherosclerosis, and the presence of calcification in the intima or in the medial layer of blood vessels is detrimental [1]. Calcification has been regarded as a silent marker of disease, but CaP crystals are known to be damaging in inflamed joints, and there is emerging evidence supporting a pro-inflammatory, destabilising effect of small CaP crystals in atherosclerosis [2–5]. Small CaP crystals (generally less than 5 mm) and other forms of particles have been shown to stimulate various cell signalling pathways resulting in profound effects on cell function, including proliferation, matrix degradation, cytokine secretion and cell death [6,7]. The micro- and nanocrystalline deposits are associated with areas of atherosclerotic plaque stress and rupture, possibly because of engulfment by phagocytic cells causing inflammation and via macrophage and VSMC death

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call